Dermatology OTC Medications Sales

Dermatology OTC Medications Sales Market Outlook

The global Dermatology OTC medications market has been valued at approximately USD 15 billion in 2023, with a projected compound annual growth rate (CAGR) of around 7% from 2025 to 2035. This growth can be attributed to several factors, including rising skin-related health concerns among the population, increasing awareness and availability of skincare products, and the expanding role of dermatology in preventing and treating conditions such as acne, eczema, and psoriasis. Additionally, the growing trend of self-medication and the accessibility of over-the-counter medications through various distribution channels such as pharmacies and online retail have significantly contributed to market expansion. With the increasing emphasis on preventive healthcare and the rising incidence of dermatological disorders globally, the demand for dermatology OTC medications is expected to remain robust in the coming years.

Growth Factor of the Market

One of the primary growth factors driving the dermatology OTC medications market is the increasing incidence of skin disorders, such as acne, eczema, and psoriasis, across various demographics. The rise in environmental pollution, coupled with changing lifestyle patterns, has led to a surge in these conditions, prompting consumers to seek effective over-the-counter solutions. Furthermore, the growing availability of a wide variety of dermatological products, including creams, lotions, and gels, formulated to address specific skin concerns has encouraged consumers to explore self-treatment options. Additionally, marketing strategies that emphasize product benefits tailored to different skin types are also playing a vital role in attracting consumers. The rapid expansion of e-commerce and online retail channels has made it easier for consumers to access a diverse range of dermatology OTC products, facilitating growth in previously underserved markets. These factors combined are positioning the dermatology OTC medications market for sustained growth in the foreseeable future.

Key Highlights of the Market

• The global dermatology OTC medications market is expected to grow at a CAGR of around 7% from 2025 to 2035.
• Increasing prevalence of skin disorders is a significant driver of market growth.
• Expansion of online retail channels has improved accessibility to dermatology products.
• Growing consumer awareness regarding skin health is prompting higher expenditure on OTC medications.
• Innovative product formulations targeting specific skin issues are enhancing market appeal.

By Product Type

Antifungal Creams :

Antifungal creams represent a significant segment within the dermatology OTC medications market, primarily used to treat fungal infections affecting the skin, such as athlete's foot, ringworm, and candidiasis. The effectiveness of these creams in eradicating fungal pathogens is a driving force behind their popularity. The increasing incidence of fungal infections, particularly among individuals with compromised immune systems or those living in humid environments, has led to heightened demand for these products. Furthermore, the availability of various antifungal agents, such as clotrimazole and miconazole, in over-the-counter formulations has made it easier for consumers to self-treat mild infections without requiring a prescription, thereby propelling sales within this category.

Acne Treatments :

Acne treatments are a dominant product type in the dermatology OTC medications market, catering to individuals of all ages affected by this common skin condition. The rising prevalence of acne, exacerbated by factors such as stress, hormonal fluctuations, and diet, has driven consumers to seek effective and accessible solutions. OTC acne treatments typically include ingredients such as benzoyl peroxide and salicylic acid, which are known for their efficacy in reducing acne lesions and preventing future breakouts. The continuous introduction of innovative products, such as gels, foams, and patches, along with targeted marketing campaigns aimed at younger consumers, has further fueled the growth of this segment.

Eczema Creams :

Eczema creams are specifically formulated to alleviate symptoms associated with atopic dermatitis and other eczema-related conditions, making them an essential part of the dermatology OTC medications landscape. The increasing prevalence of eczema, particularly among children and young adults, has heightened the demand for effective OTC solutions that provide immediate relief from itching and inflammation. The market for eczema creams has seen significant advancements, with various formulations containing ingredients like hydrocortisone and colloidal oatmeal to soothe irritated skin. As awareness of the importance of skincare routines grows, consumers are increasingly turning to these creams to manage their condition more effectively.

Psoriasis Treatments :

Psoriasis treatments are crucial for individuals suffering from this chronic autoimmune condition characterized by red, scaly patches on the skin. The increasing understanding of psoriasis and its impact on quality of life has led to a growing demand for effective OTC remedies. Products designed for psoriasis often contain active ingredients like coal tar and salicylic acid, which help to reduce inflammation and promote skin renewal. As the stigma surrounding psoriasis decreases and awareness about available treatments rises, more people are seeking over-the-counter options as a first line of defense, thereby contributing to the segment's growth in the market.

Skin Lightening Creams :

Skin lightening creams are widely used for the treatment of hyperpigmentation, dark spots, and uneven skin tone, making them a popular choice among consumers seeking cosmetic improvements. The demand for these products is particularly strong in regions with high sun exposure, where hyperpigmentation is prevalent. Ingredients such as hydroquinone, vitamin C, and kojic acid are commonly found in these formulations, targeting melanin production to achieve a brighter complexion. The rise of social media and beauty influencers has also played a significant role in promoting these products, further bolstering their popularity and market potential.

By Application

Hospitals :

Hospitals are an essential application segment for dermatology OTC medications, as they often act as a primary source of treatment for patients experiencing various skin conditions. While most dermatology OTC products are available for self-treatment, hospitals still play a critical role in educating patients about appropriate usage and providing guidance on the most effective products for specific conditions. Additionally, hospitals often stock OTC medications for patients discharged after treatment for more severe dermatological issues, bridging the gap between clinical care and home management. This enhances the overall trust in OTC products and contributes positively to market growth.

Clinics :

Clinics represent a growing application segment within the dermatology OTC medications market, as they provide a more accessible setting for patients to receive professional guidance on skin-related issues. In many cases, dermatologists recommend OTC products as part of a comprehensive treatment plan, particularly for mild to moderate skin conditions. By offering a curated selection of OTC medications, clinics enhance patient outcomes and satisfaction, as patients can easily purchase recommended products on-site. The continued rise in the number of dermatology clinics, coupled with the growing emphasis on preventive skin care, is likely to contribute positively to this segment's growth.

Pharmacies :

Pharmacies are a critical distribution channel for dermatology OTC medications, providing consumers with convenient access to a wide range of products. The presence of pharmacists allows for personalized recommendations and guidance on product selection, further enhancing consumer confidence in their purchase decisions. Many pharmacies have also embraced technology through online platforms, making it easier for customers to order products for home delivery. The continued expansion of pharmacy chains and the growing trend of integrating wellness and skincare consultations into pharmacy services underscore the vital role pharmacies play in the overall market landscape.

Online Retail :

Online retail has emerged as a significant application segment for dermatology OTC medications, driven by the increasing preference for convenience and a wider selection of products. E-commerce platforms enable consumers to browse an extensive range of skincare solutions, read customer reviews, and access detailed product information, ultimately allowing for more informed purchasing decisions. The COVID-19 pandemic accelerated the shift towards online shopping, as consumers sought safer alternatives to brick-and-mortar stores. This trend is expected to continue, with online retail remaining a key driver of growth in the dermatology OTC medications market, as more consumers become comfortable with the digital shopping experience.

By Distribution Channel

Online Stores :

Online stores have become a pivotal distribution channel in the dermatology OTC medications market, offering consumers unparalleled convenience and access to a vast array of products. These platforms allow consumers to compare prices, read reviews, and select products based on specific needs without the pressure of in-store purchases. Additionally, the ability to have products delivered directly to their homes is a significant appeal for many consumers, particularly those with busy lifestyles or mobility constraints. Moreover, online retailers often provide detailed product descriptions, usage instructions, and recommendations, enhancing the overall shopping experience. The rapid growth of e-commerce, spurred by advancements in technology and increased internet penetration, positions online stores as a primary channel for the distribution of dermatology OTC medications.

Drug Stores :

Drug stores serve as a traditional and reliable distribution channel for dermatology OTC medications, providing a physical space where consumers can access a wide selection of skincare products. These stores typically feature dedicated sections for dermatological items, which are often staffed by knowledgeable pharmacists and staff who can provide guidance and answer questions regarding product usage. The presence of drug stores in local communities enhances accessibility, allowing consumers to purchase medications in a convenient setting. Furthermore, drug stores frequently run promotions and loyalty programs, encouraging repeat purchases and fostering customer loyalty within this market segment.

Retail Pharmacies :

Retail pharmacies play a crucial role in distributing dermatology OTC medications, as they often serve as the first point of contact for consumers seeking treatment for skin-related concerns. These pharmacies are strategically located in urban and suburban areas, providing easy access to a variety of dermatological products. Retail pharmacies typically stock a broad range of OTC medications, appealing to consumers looking for immediate solutions. The presence of pharmacists in these establishments provides an added level of reassurance, as they can offer professional advice and recommendations based on individual skin types and conditions. As consumer awareness around skin health continues to rise, the role of retail pharmacies in the dermatology OTC market is expected to remain significant.

Specialty Stores :

Specialty stores, focusing exclusively on skincare and beauty products, have emerged as a notable distribution channel for dermatology OTC medications. These stores often carry a curated selection of high-quality products, catering to consumers who are willing to invest in specialized skincare solutions. The staff in specialty stores typically possess extensive knowledge about skincare, enabling them to provide personalized recommendations tailored to individual concerns. The ambiance and shopping experience offered in specialty stores often create a sense of exclusivity, attracting consumers seeking premium dermatological products. The increasing trend of consumers prioritizing skincare regimens is likely to propel the growth of specialty stores in the dermatology OTC market.

Supermarkets/Hypermarkets :

Supermarkets and hypermarkets serve as another important distribution channel for dermatology OTC medications, providing consumers with the convenience of one-stop shopping. These larger retail outlets often allocate specific sections for health and beauty products, including dermatological items, making it easy for consumers to find what they need in a familiar shopping environment. The extensive selection available in supermarkets and hypermarkets allows consumers to explore various brands and products, often at competitive prices. Additionally, promotions and discounts frequently offered in these stores can encourage consumers to try new dermatology OTC medications, ultimately contributing to market growth.

By Ingredient Type

Salicylic Acid :

Salicylic acid is a widely used ingredient in dermatology OTC medications, particularly for its effectiveness in treating acne and exfoliating the skin. As a beta hydroxy acid, it penetrates deep into the pores to dissolve excess oil and dead skin cells, making it an ideal choice for individuals with oily and acne-prone skin. The increasing incidence of acne, especially among teenagers and young adults, has fueled the demand for products containing salicylic acid. Additionally, its anti-inflammatory properties further enhance its appeal, as it helps reduce redness and swelling associated with breakouts. The growing awareness of the benefits of salicylic acid and its proven efficacy in various formulations contribute significantly to its prominence in the dermatology OTC medications market.

Benzoyl Peroxide :

Benzoyl peroxide is another key ingredient commonly found in dermatology OTC medications, primarily used for the treatment of acne. Renowned for its antibacterial properties, benzoyl peroxide effectively targets the bacteria responsible for acne, helping to reduce the number and severity of breakouts. Its ability to promote skin cell turnover and prevent clogged pores further enhances its efficacy as an active ingredient. The rising prevalence of acne, combined with consumer preference for readily available OTC treatments, ensures a steady demand for products containing benzoyl peroxide. As skincare enthusiasts become increasingly informed about acne-fighting ingredients, the popularity of benzoyl peroxide is likely to remain strong in the market.

Hydrocortisone :

Hydrocortisone is a topical corticosteroid widely used in dermatology OTC medications to alleviate inflammation, itching, and irritation associated with various skin conditions, such as eczema, dermatitis, and allergic reactions. Its anti-inflammatory properties make it one of the most effective treatments for soothing inflamed skin, leading to its widespread use in over-the-counter creams and ointments. The growing prevalence of skin allergies and inflammatory conditions has driven demand for hydrocortisone-based products, as consumers seek relief from uncomfortable symptoms. As awareness of the benefits of hydrocortisone grows, its prominence in the dermatology OTC medications market is expected to continue rising.

Retinoids :

Retinoids, derived from vitamin A, are increasingly recognized for their effectiveness in treating various skin concerns, including acne, fine lines, and hyperpigmentation. These compounds work by accelerating cell turnover, promoting collagen production, and preventing clogged pores, making them a popular choice in dermatology OTC products. The growing interest in anti-aging skincare and the demand for effective treatments for acne have contributed to the rising popularity of retinoid-containing products. As consumers become more educated about the benefits of retinoids and their role in achieving healthy skin, the demand for these ingredients in the dermatology OTC medications market is expected to grow.

Vitamin C :

Vitamin C is a powerful antioxidant widely used in dermatology OTC medications for its skin-brightening and anti-aging properties. Known for its ability to neutralize free radicals, promote collagen synthesis, and reduce hyperpigmentation, vitamin C has become a popular ingredient among consumers seeking healthier, more radiant skin. The increasing awareness of the importance of antioxidants in skincare has led to a surge in demand for vitamin C-infused products. As more consumers incorporate vitamin C into their daily skincare routines, its significance in the dermatology OTC medications market continues to grow, driving innovation and product development.

By Region

North America is the largest market for dermatology OTC medications, accounting for over 35% of the global market share in 2023. The region's growth is primarily driven by high consumer awareness of skincare and increasing prevalence of skin disorders such as acne and eczema. Additionally, the presence of a well-established healthcare infrastructure and a wide variety of available OTC products contribute to North America's leading position. The CAGR for the North American dermatology OTC medications market is projected to be around 6.5% from 2025 to 2035, as more consumers embrace self-care and preventative skincare.

Europe follows closely behind North America, capturing approximately 30% of the global market share in 2023. The region's growing demand for dermatology OTC products can be attributed to an aging population, an increase in skin-related health issues, and an expanding cosmetic industry. Countries such as Germany, France, and the UK are significant contributors to the market, with a preference for natural and organic ingredients driving the launch of new products. The European dermatology OTC medications market is expected to witness a CAGR of around 7% during the forecast period, fueled by rising consumer awareness and the introduction of innovative products.

Opportunities

The dermatology OTC medications market presents numerous opportunities for growth and innovation, particularly as consumers increasingly prioritize skin health and well-being. One of the most significant opportunities lies in the development of personalized skincare solutions tailored to specific skin types and concerns. As consumers become more educated about their skin and its unique needs, there is a growing demand for products that address individual concerns such as acne, aging, and pigmentation issues. Companies that invest in research and development to create specialized formulations or customize existing products based on consumer preferences will likely capture a larger share of the market. Additionally, integrating technology into skincare, such as AI-driven diagnostics and tailored product recommendations, can further enhance the consumer experience and drive engagement.

Another opportunity in the dermatology OTC medications market is the expansion of distribution channels, particularly through online platforms. The COVID-19 pandemic accelerated the adoption of e-commerce, and as consumers have become accustomed to the convenience of shopping online, companies must focus on enhancing their digital presence. Leveraging social media and influencer marketing can effectively reach target audiences and promote products. Furthermore, international expansion into emerging markets presents a valuable opportunity for growth, as rising disposable incomes and increasing awareness of skincare may drive demand for dermatology OTC medications in these regions. Companies that position themselves strategically in these markets will be well-poised to take advantage of the burgeoning consumer base.

Threats

While the dermatology OTC medications market offers numerous growth opportunities, it also faces several threats that could hinder progress. One major concern is the increasing competition from both established brands and new entrants. The market is becoming increasingly saturated, with numerous players vying for consumer attention and market share. This competitive landscape can lead to price wars, eroding profit margins for companies. Additionally, the rapid pace of innovation and the introduction of new products mean that companies must continually invest in research and development to stay ahead of the curve. Failure to keep up with market trends and consumer preferences could result in lost opportunities and market share.

Another threat to the dermatology OTC medications market is the potential for regulatory challenges and changes in legislation surrounding the sale of over-the-counter products. Governments and regulatory bodies are becoming more stringent in their approval processes and safety standards, which may delay product launches and increase compliance costs for manufacturers. Furthermore, growing consumer awareness regarding the safety and efficacy of ingredients in skincare products could lead to increased scrutiny of certain active ingredients, potentially limiting their use in OTC formulations. Companies must navigate these regulatory landscapes carefully to minimize disruptions and ensure continued market access.

Competitor Outlook

• Johnson & Johnson
• Procter & Gamble
• Galderma S.A.
• Beiersdorf AG
• Valeant Pharmaceuticals
• CeraVe
• Neutrogena
• La Roche-Posay
• SkinCeuticals
• Burt's Bees
• Unilever
• Avène
• Olay
• Estee Lauder Companies
• L'Oréal

The competitive landscape of the dermatology OTC medications market is characterized by a mix of established pharmaceutical companies and emerging brands specializing in skincare. Major players such as Johnson & Johnson and Procter & Gamble have solidified their positions through extensive product lines and robust marketing strategies, catering to a broad consumer base. These companies leverage their extensive distribution networks and brand recognition to maintain dominance in the market. Additionally, they continuously invest in research and development to innovate and expand their product offerings, ensuring they meet the evolving needs of consumers.

Emerging brands and niche players also contribute to the competitive landscape by focusing on specific market segments or unique formulations, often using natural and organic ingredients to cater to health-conscious consumers. Companies like CeraVe and SkinCeuticals have gained popularity for their dermatologist-developed products that emphasize efficacy while prioritizing skin health. Moreover, these brands utilize digital marketing strategies to engage with consumers directly, building loyalty through authentic messaging and community involvement. As consumer preferences shift towards transparency and ingredient integrity, these emerging brands are well-positioned to capture market share from traditional players.

Furthermore, collaboration and partnerships between skincare brands and dermatological professionals are becoming increasingly prevalent in the industry. By working closely with dermatologists, companies can enhance their credibility and improve product formulations based on expert insights. This collaboration not only fosters consumer trust but also helps brands develop targeted solutions for specific skin concerns. As the market continues to evolve, companies that effectively navigate the competitive landscape through innovation, strategic partnerships, and consumer engagement will be well-equipped to succeed in the dermatology OTC medications market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Olay
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 CeraVe
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Unilever
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Neutrogena
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Burt's Bees
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Avène
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Beiersdorf AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Galderma S.A.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 SkinCeuticals
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 L'Oréal
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 La Roche-Posay
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Procter & Gamble
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Johnson & Johnson
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Estee Lauder Companies
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Valeant Pharmaceuticals
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Dermatology OTC Medications Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Pharmacies
    • 6.1.4 Online Retail
  • 6.2 Dermatology OTC Medications Sales Market, By Product Type
    • 6.2.1 Antifungal Creams
    • 6.2.2 Acne Treatments
    • 6.2.3 Eczema Creams
    • 6.2.4 Psoriasis Treatments
    • 6.2.5 Skin Lightening Creams
  • 6.3 Dermatology OTC Medications Sales Market, By Ingredient Type
    • 6.3.1 Salicylic Acid
    • 6.3.2 Benzoyl Peroxide
    • 6.3.3 Hydrocortisone
    • 6.3.4 Retinoids
    • 6.3.5 Vitamin C
  • 6.4 Dermatology OTC Medications Sales Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Drug Stores
    • 6.4.3 Retail Pharmacies
    • 6.4.4 Specialty Stores
    • 6.4.5 Supermarkets/Hypermarkets

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Dermatology OTC Medications Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Dermatology OTC Medications Sales market is categorized based on

By Product Type

• Antifungal Creams
• Acne Treatments
• Eczema Creams
• Psoriasis Treatments
• Skin Lightening Creams

By Application

• Hospitals
• Clinics
• Pharmacies
• Online Retail

By Distribution Channel

• Online Stores
• Drug Stores
• Retail Pharmacies
• Specialty Stores
• Supermarkets/Hypermarkets

By Ingredient Type

• Salicylic Acid
• Benzoyl Peroxide
• Hydrocortisone
• Retinoids
• Vitamin C

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Johnson & Johnson
• Procter & Gamble
• Galderma S.A.
• Beiersdorf AG
• Valeant Pharmaceuticals
• CeraVe
• Neutrogena
• La Roche-Posay
• SkinCeuticals
• Burt's Bees
• Unilever
• Avène
• Olay
• Estee Lauder Companies
• L'Oréal